Instylla Announces Completion of $30MM EQUITY Financing
Secured financing advances Instylla’s clinical trials and commercialization readiness BEDFORD, Mass., – August 15, 2023 – Instylla, Inc., a privately
Pioneering Medical Innovations
Pioneering Medical Innovations
Secured financing advances Instylla’s clinical trials and commercialization readiness BEDFORD, Mass., – August 15, 2023 – Instylla, Inc., a privately
Imperative Care has announced a new organizational structure designed to accelerate the company’s growth across its businesses. According to an
CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc., a medical technology company elevating care for people affected by stroke and other ischemic diseases,
Late-Breaking Data Presented at the Society of NeuroInterventional Surgery Annual Meeting Demonstrate High Rates of Successful Reperfusion and Rapid Procedure
Initial results from a novel stroke recovery program demonstrate excellent achievement of functional independence and low hospital readmissions July 31,
First Patients Treated with Zoom 88 Support at Several Leading Stroke Centers Across the U.S. July 25, 2023 08:00 AM
CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, a medical technology company developing connected innovations to elevate care for people affected by stroke and other ischemic diseases, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Zoom™ 88 Large Distal Platform (LDP) Support, a portfolio expansion of the company’s Zoom 88 Large Distal Platform.
New Data to Demonstrate the Real-World Benefits and Utility of the Company’s Stroke Treatment Portfolio July 20, 2023 08:00 AM
New, Real-World Data to Provide Insights on the Safety and Efficacy of the Company’s Zoom Family of Products to Treat
Preliminary Data Presented at the Society of NeuroInterventional Surgery Annual Meeting Highlight Benefits of Zoom for Mechanical Thrombectomy July 26,